Engineered Mesenchymal Stem Cells as a Biotherapy Platform for Targeted Photodynamic Immunotherapy of Breast Cancer-Reference-Cited by-同舟云学术

Engineered Mesenchymal Stem Cells as a Biotherapy Platform for Targeted Photodynamic Immunotherapy of Breast Cancer

Published:2022-01-12 Issue:6 Volume:11 Page:2101375
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv Healthcare Materials

Author:

Zhang Hanxi¹,Feng Yi¹,Xie Xiaoxue¹,Song Ting¹,Yang Geng¹,Su Qingqing¹,Li Tingting¹,Li Shun¹,Wu Chunhui¹,You Fengming²,Liu Yiyao¹²^ORCID,Yang Hong¹

Affiliation:

1. Department of Biophysics School of Life Science and Technology University of Electronic Science and Technology of China Chengdu Sichuan 610054 P. R. China

2. TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province Hospital of Chengdu University of Traditional Chinese Medicine No. 39 Shi‐er‐qiao Road Chengdu Sichuan 610072 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202101375

Reference60 articles.

1. Breast cancer

2. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer

3. Advances in cancer immunotherapy 2019 – latest trends